Literature DB >> 11165961

Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function.

R Bigi1, A Desideri, J J Bax, A Galati, C Coletta, C Fiorentini, P M Fioretti.   

Abstract

Dobutamine stress echocardiography (DSE) accurately detects viable myocardium and residual ischemia in patients with acute myocardial infarction (AMI). The prognostic interaction of viability and ischemia has not been completely clarified in these patients. This study assesses the long-term effect of viability, ischemia, or their combination on survival in patients with AMI and mildly impaired left ventricular (LV) function. Four hundred eleven patients (age 57 +/- 9 years) underwent predischarge DSE (up to 40 microg/kg/min plus atropine if needed) after uncomplicated AMI and were prospectively followed for 23 months (range 1 to 78). According to DSE findings, patients were divided into 4 groups: viability only, ischemia only, combination of viability and ischemia, and scar. Adverse outcome occurred in 64 patients: 34 patients had hard events (9 cardiac deaths, 25 nonfatal AMI) and 30 patients had unstable angina requiring hospitalization. The combination of viability and ischemia, diabetes mellitus, and non-Q-wave AMI were significant predictors of all events at univariate and multivariate analysis. The same variables were also univariate predictors of hard events, but multivariate analysis indicated only the combination of viability and ischemia and diabetes as independent predictors. The event-free survival of patients with combined viability and ischemia was significantly lower (hazard ratio 3 [95% confidence interval 1.8 to 11]) compared with patients with ischemia only. Thus, viability and ischemia show a significant adverse prognostic interaction in patients with AMI and preserved LV function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165961     DOI: 10.1016/s0002-9149(00)01359-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT.

Authors:  James A Arrighi; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

2.  Infarct zone viability influences ventricular remodelling after late recanalisation of an occluded infarct related artery.

Authors:  N G Bellenger; Z Yousef; K Rajappan; M S Marber; D J Pennell
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

3.  Left ventricular remodeling after late revascularization correlates with baseline viability.

Authors:  Pravin K Goel; Tanuj Bhatia; Aditya Kapoor; Sanjay Gambhir; Prasanta K Pradhan; Sukanta Barai; Satyendra Tewari; Naveen Garg; Sudeep Kumar; Suruchi Jain; Ponnusamy Madhusudan; Siddegowda Murthy
Journal:  Tex Heart Inst J       Date:  2014-08-01

4.  Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial).

Authors:  Ramon B van Loon; Gerrit Veen; Leo H B Baur; Otto Kamp; Jean G F Bronzwaer; Jos W R Twisk; Freek W A Verheugt; Albert C van Rossum
Journal:  Trials       Date:  2012-01-03       Impact factor: 2.279

5.  Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial).

Authors:  Ramon B van Loon; Gerrit Veen; Otto Kamp; Jean Gf Bronzwaer; Cees A Visser; Frans C Visser
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-11-11

6.  Predictors of segmental myocardial functional recovery in patients after an acute ST-Elevation myocardial infarction.

Authors:  Kenneth Mangion; David Carrick; Guillaume Clerfond; Christopher Rush; Christie McComb; Keith G Oldroyd; Mark C Petrie; Hany Eteiba; Mitchell Lindsay; Margaret McEntegart; Stuart Hood; Stuart Watkins; Andrew Davie; Daniel A Auger; Xiaodong Zhong; Frederick H Epstein; Caroline E Haig; Colin Berry
Journal:  Eur J Radiol       Date:  2019-01-14       Impact factor: 3.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.